We analyzed the ordering and impact of the first 171 fee-for-service cardiovascular nuclear medicine procedures at one hospital. The ordering physicians said 72% of the study results were useful and 28% contributed to changes in patient management. Experienced cardiology reviewers, however, felt that only 65% of studies were appropriately ordered, that 97% of appropriately ordered studies provided potentially useful information, and that 12% of all studies made important contributions to appropriate changes in patient management. The reviewers were most likely to rate exercise thallium procedures and procedures ordered by physicians from distant hospitals as being appropriately ordered and having important clinical impact. We conclude that (1) ordering physicians and reviewers may disagree substantially in their estimates of the impact of a diagnostic test; and (2) although a test may yield important information in appropriate patients, its total clinical impact will depend on how often it is suitably ordered and used.
CARDIAC NUCLEAR MEDICINE procedures exemplify the recently developed noninvasive techniques that may increase diagnostic precision at virtually no risk to the patient. Such procedures usually cost far less than the invasive procedures that they are designed to replace, but their widespread use may actually increase total medical expenditures.
Cardiac nuclear medicine studies may have broad clinical applicability in identifying new or old myocardial infarction, diagnosing acute myocardial ischemia, or assessing left ventricular function. '16 However, early investigations, which usually estimate the sensitivity, specificity and predictive accuracy of a new diagnostic procedure in test populations, represent just the first step in establishing clinical efficacy.
A new procedure must be tested on a broad spectrum of patients to determine its proper clinical role.7 In an attempt to deal with the issue of the relevance of these newly available procedures, we analyzed the patientcare impact of clinically requested cardiovascular nuclear medicine procedures performed at Yale-New Haven Hospital immediately after these studies became available on a routine basis.
Methods
This analysis was based on the first 171 consecutive cardiovascular nuclear medicine procedures requested for clinical purposes after such procedures became routinely available on a demand, fee-for-service basis. The procedures were performed on 132 different patients (98 patients had one study, 30 patients had two studies, and four patients had three studies) between late August and early November 1977 using both portable and stationary scintillation cameras. Other procedures performed during the same period as part of investigational protocols were not included in this analysis.
Because both reviewers could not interview the ordering physician simultaneously and because we feared that duplicate interviews might introduce inconsistencies, one investigator abstracted all pertinent patient information related to the nuclear medicine procedure and personally spoke to each ordering physician as soon as possible after each procedure was performed. During the interview, each ordering physician was asked (I) the reasons for obtaining the procedure, (2) why the procedure result was or was not found to be useful, (3) what patient management was planned or implemented, (4) whether the result of the procedure led to a change in management, and (5) what other procedures or medical expenses were avoided because of the nuclear medicine study. With the help of the ordering physician, we classified the reasons for ordering into one or more general categories: to make a diagnosis, to plan management, to define the extent of a known disease, to estimate prognosis, to reassure a physician, and to reassure the patient.
Our sample included four types of cardiovascular nuclear medicine procedures, all of which were available from the beginning of the analysis: (1) resting left ventricular function studies to assess left ventricular ejection fraction and regional wall motion; (2) technetium-99m stannous pryophosphate acute infarct imaging to detect acute myocardial infarction as zones of increased radionuclide accumulation; (3) rest thallium-201 myocardial perfusion imaging to assess regional myocardial perfusion abnormalities due to either old or new infarction; and (4) exercise thallium-201 myocardial perfusion imaging studies to detect reversible perfusion abnormalities consistent with transient ischemia. Thallium-201 redistribution studies, which are obtained at an interval after exercise imaging, and exercise left ventricular function studies were performed only on an investigative basis during the study and thus were not included in this analysis. The specific methods for obtaining and processing the cardiac nuclear medicine procedures were reported previously." 5
Review Process
To obtain a detailed, independent assessment of the ordering and clinical impact of each of the 171 procedures, the abstracted clinical information and the data obtained from the interview with the ordering physician were presented for review to two full-time faculty cardiologists. Each reviewer regularly served as an attending cardiologist on the inpatient services and had an active outpatient practice and was knowledgeable as to the current clinical uses and literature of cardiac nuclear medicine, but was not primarily involved in cardiac nuclear medicine research. Without knowing the identity of the patient or the ordering physician, the two reviewers answered 10 questions for each of the 171 procedures, based on the state of the art at the time the procedure was ordered:
(1) Did the ordering physician have a clear clinical purpose for obtaining the study? (2) Did the reviewer share the questions or uncertainties for which the study was obtained?
(3) Was the study the best test to obtain in terms of the stated reasons for ordering it at that particular time in the evaluation of the patient? (4) Based upon available scientific data, did the study have documented or at least presumed efficacy for answering the question posed by the ordering physician? (5) Did the ordering physician understand the meaning of the report of the study's results? (6) Did the ordering physician appropriately integrate the study result with other available data? (7) Was the study result useful in answering the questions that prompted the physician to order the test? (8) Assuming a proper interpretation for all data, how useful would the study result have been to someone trying to answer the questions originally posed by the ordering physician? (9) Assuming a proper interpretation for all available clinical and laboratory data, should the study result have led to a change in patient management? (10) Was the patient appropriately managed? For each of these questions, a reviewer's opinion could be positive, neutral or negative. Because of the wide variety of clinical situations, the reviewers used implicit criteria derived from their familiarity with the and their knowledge of how these procedures compared with competing or complementary techniques at the time the procedure was obtained. Our two reviewers and our review grading system were chosen so as to ensure that reasonable variations in practice patterns would not be negatively judged. First, the two reviewers had different areas of expertise and interest within the subspecialty of cardiology; one represented the junior faculty and one the senior faculty. Second, the review system graded an overall review on each question as positive if one reviewer gave a positive response (regardless of the other reviewer's response), or if both reviewers were neutral; and negative if both reviewers gave a negative response, or if one reviewer gave a negative response and the other reviewer was neutral.
On question 8, positive responses were further subdivided: the reviewers termed a study crucial if it supplied conclusive information not previously available; contributory if it provided important data for a patient in whom no test ordered thus far could be diagnostic; or confirmatory if it substantiated a conclusion that otherwise would have remained open to doubt. On question 8, the usefulness of the study was classified according to the highest degree of usefulness indicated by either of the two reviewers.
Statistical Methods
Univariate two-by-two comparisons were performed using the Fisher exact test, and univariate two-by-three and two-by-four comparisons were performed using the chi-square statistic with the appropriate degrees of freedom. Multivariate significance testing was performed by analysis of variance and covariance using a standard statistical package.8
Results
The 171 consecutive procedures included 51 rest left ventricular function studies, 50 technetium-99m stannous pyrophosphate acute infarct studies, 34 rest thallium-20 1 myocardial perfusion imaging studies and 36 exercise thallium studies. The thallium studies included 12 patients with separate thallium injections both at exercise and at rest and 46 patients with either a rest or an exercise study but not both.
The ordering physicians were: house officers, 33 studies (19%); internists 42 studies (25%); community cardiologists in private practice, 35 studies (20%); and full-time faculty cardiologists, 61 studies (36%). Twenty-seven studies were ordered on outpatients by distant physicians who were from other cities and did not admit or refer patients routinely to our hospital. Twenty-eight clinical studies (16%) were ordered by faculty cardiologists whose primary area of investigative interest was cardiac nuclear medicine, and another 27 studies (16%) were ordered by other physicians who had participated in cardiac nuclear medicine research but whose primary investigative inclinical value of cardiac nuclear medicine procedures 681 terests were elsewhere. 
*A sirgle study was ofteni ordered for more than one reason.
tAinalysis of whether the four types of studies were eqtually likely to be ordered for that pturpose based onr the chi-square statistic with 3 degrees of freedom.
Interview with the Ordering Physician
Reasons.for Ordering Studies The 171 cardiac nuclear medicine studies were ordered for 308 distinct clinical reasons (mean 1.8 reasons per study) (table 1). These reasons included: to plan management (65% of studies), to make a diagnosis (60%), to reassure a physician (28%), to define the extent of a known disease (14%), to estimate prognosis (8%), and to reassure the patient (6%). Infarct pyrophosphate studies were more likely than other cardiovascular nuclear medicine studies to be ordered to make a diagnosis or to plan management, whereas left ventricular function studies were more likely than others to be ordered for estimating prognosis or for defining the extent of a known disease. Exercise thallium studies were the most common type obtained primarily to reassure the patient when the physician felt the study was otherwise unnecessary.
Usefulness According to the Ordering Physician
According to the ordering physicians, 123 (72%) of the 171 studies were useful and another 22 studies (13%) would have been useful if their results had been different. These latter 22 studies were usually negative or normal studies in patients in whom the ordering physicians felt that only positive or abnormal studies would be useful. For example, one ordering physician said that a normal infarct pyrophosphate study was not useful in his patient with classic unstable angina, but that it would have been useful if it were abnormal. Finally, the ordering physicians felt that 26 studies (16%) would not have been useful regardless of their results. The usefulness of a study according to the ordering physician was not dependent on the type of study, the type of physician or the reasons for ordering the study.
Changes in Management by Ordering Physicians
The ordering physicians said that 48 of the 171 studies (28%) contributed to a change in management, 55 studies (32%) would have contributed if their results had been different, and the other 68 studies (40%) would not have contributed to a change in management regardless of their results. According to the ordering physicians, the 171 nuclear medicine procedures meaningfully contributed to the decision not to perform cardiac catheterization in 13 cases and to the decision to perform cardiac catheterization in two cases. In three other cases, the studies dissuaded the ordering physician from recommending cardiac surgery. In addition, the ordering physicians cited three positive infarct pyrophosphate studies as being very important in diagnosing myocardial infarctions. However, the negative infarct pyrophosphate and/or rest thallium studies that helped to rule out myocardial infarctions never substituted for the ordering of at least 3 days of cardiac enzymes and ECGs and never decreased the number of days spent in the coronary care unit.
Reviewers' Assessments

Ordering ofthe Studies
The reviewers felt that the ordering physicians expressed clinical reasons for obtaining 135 of the 171 studies (79%) ( fig. 1 ). In 119 cases (70%), the reviewers agreed with the clinical reasons of the ordering physicians. However, in seven of the 119 studies that were ordered for agreed-upon clinical indications, as well as in an additional 24 of the cases without agreedupon clinical indications, the reviewers believed either that another diagnostic test was preferable to the requested cardiac nuclear medicine procedure or that the procedure could not be presumed efficacious for answering the ordering physician's questions. Thus, according to the reviewers, 112 of the 171 studies (65%) represented the most efficacious way to answer a clinical question. These 1 12 studies were considered appropriately ordered.
Potential Usefulness ofthe Studies
If all available clinical data were properly interpreted, the reviewers felt that 11 study results provided crucial information (see Methods section for definition) when other data were unclear, another 89 results provided contributory information when no single test was diagnostic, and nine others provided important confirmatory information (table 2) . Thus, the reviewers felt that 109 of the 112 appropriately ordered studies yielded results that were potentially useful to the ordering physician. Although the ordering physicians frequently considered a study not useful because of a negative or normal result, the reviewers believed that non-usefulness was independent of the study result and was almost always attributable to the original reasons for ordering the study.
Interpretation ofthe Study Results
The reviewers felt that 18 of the 171 studies (1 1%), including 10 of the appropriately ordered studies, were misinterpreted because the ordering physician did not understand the meaning of the report of the study's therapeutic impact FIGURE 1. This flow sheet summarizes the reviewers' opinions toward all 171 studies. The percentages in the left column reflect the studies that were approved for all preceding criteria andfor the criterion on that line. The percentages in the right column indicate the studies that were approved for all preceding criteria but were not approved for the criterion on that line.
Changes in Management
Of the 48 studies that had contributed to changes in patient management according to the ordering physician, the reviewers felt that 20 studies were appropriately ordered, potentially useful, correctly interpreted and also truly important for a change to a new and appropriate management. Another 21 of these 48 studies were associated with an appropriate change in management, but the reviewers felt the same appropriate decisions could be reached without the study. In seven cases, the reviewers felt the study was used inappropriately to change management. (See the Appendix for a brief case history demonstrating each of three types of conclusions reached by the reviewers.) The reviewers felt that cardiac nuclear medicine studies made a necessary contribution to the appropriate avoidance of five cardiac catheterizations and one cardiac operation, compared with 13 and three, respectively according to the statements of the ordering physicians.
A nalysis by Type ofNuclear Medicine Study
According to the reviewers, appropriate ordering was most likely for exercise thallium studies and least likely for left ventricular function studies and for rest thallium studies (table 3) . As for true impact on patient management, however, infarct pyrophosphate studies rated poorest: only three of the 50 such studies were felt to have true therapeutic impact. In fact, the infarct pyrophosphate and rest thallium studies ordered to diagnose myocardial infarction had true therapeutic impact in only three of 72 cases, while other types of procedures had such impact in 18 of 99 cases (p < 0.01; table 4 ). An analysis of individual cases showed that true management impact was most likely in several definable clinical situations, usually in instances where alternative conventional means of evaluation were inadequate, unavailable or uninterpretable.
A nalysis by Category ofOrdering Physician
According to the reviewers, cardiac nuclear medicine procedures obtained by distant physicians (who did not usually refer or admit patients to Yale-New Haven Hospital) were more likely to be ap- propriately ordered, to be properly useful and to have true patient-management impact (but not to be properly interpreted) than were studies ordered by local community, house staff, or faculty physicians (table 5). By analysis of variance, both the type of procedure and the location (local vs distant) of the physician were independently related to review ratings. However, other physician characteristics such as specialty, level of training, academic affiliation, and degree of prior sophistication with cardiac nuclear medicine techniques did not correlate with the reviewers' assessments of ordering, interpretation, usefulness or management impact. Thus, the physician's distance from the hospital, and presumably also the travel time and inconvenience experienced by his or her patients, represented the only correlation between the type of ordering physician and the reviewers' assessments.
Economic Impact Based on the reports of the ordering physicians, both exercise thallium studies and left ventricular function studies resulted in net direct economic savings, while infarct pyrophosphate studies and resting thallium studies generated more charges than they saved (table 6) . Overall, the ordering physicians stated that the 171 studies saved a net of $28,000 in patient charges. According to the reviewers, however, only exercise thallium procedures resulted in direct medical savings, and the 171 procedures were estimated to generate charges of almost $1 1,000 more than the procedures or days of hospitalization that they avoided. However, the economic analysis in table 6 represents an interplay between the cost effectiveness of cardiac nuclear medicine procedures per se and the way in which physicians actually ordered them. If the economic analysis was limited to those 112 studies that were appropriately ordered, patient charges would about equal the reviewer-estimated direct economnic savings. Thus, appropriately ordered studies avoided the morbidity and inconvenience of five cardiac catheterizations and one cardiac operation without generating any extra direct medical charges.
Discussion
The analysis of the clinical impact of a new diagnostic procedure is as important as an analysis of its sensitivity and specificity. Our methods for estimating impact had two important characteristics. First, we contrasted the opinions of the ordering physicians to those of independent reviewers. Although no review process can be totally unbiased, we tried to accept reasonable variations in practice patterns both by selecting reviewers with divergent interests and backgrounds and by defining approval as a positive response from either reviewer or a neutral response from two reviewers. Nevertheless, as emphasized by the analysis of direct economic costsavings, ordering physicians and reviewers sometimes had substantial disagreements.
Second, our review process assessed the individual components necessary for appropriate impact: appropriate ordering, potential usefulness, accurate interpretation and true therapeutic contribution. Each of these components was independently important in the analysis of a procedure's role in medical decisionmaking ( fig. 1 ).
Study-specific Observations
This study was conducted when cardiovascular nuclear medicine procedures first became available for in parentheses represent net routine clinical purposes at our hospital. Within this clinical setting, exercise thallium studies ordered to detect the presence of transient myocardial ischemia (and to plan indicated management) had the largest impact. Because exercise thallium imaging has a 90% specificity but a lower sensitivity,3' the procedure often contributed to appropriate impact but occasionally led either to study misinterpretation or to inappropriate impact. As emphasized by recent analyses,9'-1 no noninvasive procedure precisely predicts coronary arteriographic findings. Because they are reasonably independent of stress electrocardiographic results4 and are also more accurate in certain groups of patients, exercise thallium studies will have major impact when their results make a clinically important difference in assessing the likelihood of coronary artery disease. Although exercise left ventricular function studies were not included in this analysis, their accuracy12 13 and their presumed potential clinical impact would be expected to be similar to exercise thallium imaging.
The major impact of rest thallium studies was as a comparison to exercise thallium procedures. Recent data on the similarity between the exercise thallium study's redistribution phase (about 4 hours after the exercise study) and a standard rest thallium study14' 15 suggest that many patients will not need a second injection of the expensive nuclide. If our nuclear medicine laboratory had routinely substituted redistribution thallium studies for "comparison" rest thallium studies, $2760 in charges would have been avoided, but our economic analyses would not have changed appreciably.
When ordered to diagnose acute myocardial infarction, both rest thallium studies and infarct pyrophosphate studies fared poorly in the review process because ordering physicians never used such studies in lieu of the routine analysis of serial enzymes and ECGs. If standard tests were diagnostic of infarction, rest thallium and infarct pyrophosphate studies were considered inappropriately ordered. If the standard 3 days of enzymes and ECGs were nondiagnostic, infarct pyrophosphate studies usually were not helpful." 1-8 However, infarct pyrophosphate studies, usually accompanied by lactic dehydrogenase isoenzymes,'9 may be the method of choice for diagnosing acute myocardial infarction in patients who present about 48 or more hours after the acute event.
Rest left ventricular function studies were rated poorly by our reviewers when they were ordered to estimate prognosis or to define the extent of a known disease. However, left ventricular function studies may have major management impact when they are well standardized, have known intrinsic variabilities,20' 21 and are used to answer clinically important questions concerning cardiac performance.22
General Observations
Because of the recent cardiology literature and the increasing local clinical familiarity with cardiac nuclear medicine procedures, we hope that the future ordering and impact of the procedures at our hospital will be better than in these first 171 cases. Nevertheless, our 65% rate for appropriate ordering was identical to a rate reported by Marton and colleagues for upper gastrointestinal series.23 Our correlates of appropriate ordering and impact for cardiac nuclear medicine procedures suggest that patient inconvenience may be a chief deterrent to improper ordering and that increased educational efforts or screening by study providers may not be sufficient to improve clinical impact.
Previous investigators have noted that ordering physicians or patients reported a change in management after 23% of upper gastrointestinal series,23 199% of computerized cranial tomography studies,24 and 17% of computerized body tomography studies. 25 When such management changes were subject to review, however, the rate of change truly attributable to upper gastrointestinal series fell from 21% to 7%,23
These findings, as well as the results of the present study, indicate that from a methodologic standpoint, review processes seem necessary to assess the therapeutic impact of diagnostic tests; and from a clinical standpoint, a subspecialty consultation, or even review of a case with a colleague sometimes may be preferable to ordering a diagnostic test.
Individual cardiac nuclear medicine procedures can be very valuable, and the techniques have a potentially important role in cardiology. However, the overall cost effectiveness of a procedure in actual medical practice depends on how physicians order and use it as well as on its inherent qualities. Thus, widespread inappropriate ordering or use could negate the potential impact of cardiac nuclear medicine; the procedures can be maximally cost effective only if inappropriate ordering and use are minimized. Because many hospitals have recently begun or are introducing cardiac nuclear medicine procedures on a demand feefor-service basis, an understanding of our early experience may help maximize the future clinical 
